鉴定剖腹产痕怀孕的风险因素,基于倾向性比分匹配的比分
Manman Liu1, Feng Zeng1, Qiaoqiao Zheng1
1Department of Gynecology and Obstetrics, Taizhou Hospital of Zhejiang Province, Zhejiang University, Linhai, China.
概括
多次剖腹产和堕胎增加了剖腹产痕怀孕 (CSP) 的风险. 试产,剖腹产间隔较长以及第三级医院的手术是对CSP的保护因素.
科学领域:
- 生殖医学 生殖医学
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 剖腹产痕怀孕 (CSP) 是一种罕见但严重的并发症.
- 识别风险因素对于早期诊断和管理至关重要.
研究的目的:
- 调查与剖腹产痕怀孕 (CSP) 相关的潜在风险因素.
主要方法:
- 一项病例控制研究,涉及499名患有CSP的妇女和499名匹配的对照.
- 收集了人口统计和妊娠史数据.
- 统计分析包括t测试,奇平方测试,后勤回归和ROC曲线分析.
主要成果:
- 多重堕胎和剖腹产被确定为CSP的重大风险因素.
- 在之前的剖腹产前进行分娩试验,剖腹产间隔较长,以及在三级医院的手术被发现具有保护作用.
- 后勤回归确定了这些因素的特定赔率比率.
结论:
- 堕胎和剖腹产的数量是CSP的关键风险因素.
- 诸如分娩试验,延长剖腹产间隔和第三级医院手术等因素可能会降低CSP发生率.
相关概念视频
Regression Toward the Mean
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Odds Ratio
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
Strategies for Assessing and Addressing Confounding
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...


